BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6832096)

  • 1. Prostaglandin hydroperoxidase-catalyzed activation of certain N-substituted aryl renal and bladder carcinogens.
    Zenser TV; Cohen SM; Mattammal MB; Wise RW; Rapp NS; Davis BB
    Environ Health Perspect; 1983 Mar; 49():33-41. PubMed ID: 6832096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxidase metabolism of the urinary bladder carcinogen 2-amino-4-(5-nitro-2-furyl)thiazole.
    Wise RW; Zenser TV; Davis BB
    Cancer Res; 1983 Apr; 43(4):1518-22. PubMed ID: 6403225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin H synthase metabolism of the urinary bladder carcinogens benzidine and ANFT.
    Wise RW; Zenser TV; Davis BB
    Carcinogenesis; 1983; 4(3):285-9. PubMed ID: 6299601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of prostaglandin H synthase-catalyzed binding of two 5-nitrofuran urinary bladder carcinogens.
    Zenser TV; Palmier MO; Mattammal MB; Bolla RI; Davis BB
    J Pharmacol Exp Ther; 1983 Oct; 227(1):139-43. PubMed ID: 6413679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic activation of the carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]acetamide by prostaglandin H synthase.
    Zenser TV; Palmier MO; Mattammal MB; Davis BB
    Carcinogenesis; 1984 Oct; 5(10):1225-30. PubMed ID: 6435896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of renal metabolism and excretion in 5-nitrofuran-induced uroepithelial cancer in the rat.
    Spry LA; Zenser TV; Cohen SM; Davis BB
    J Clin Invest; 1985 Sep; 76(3):1025-31. PubMed ID: 4044826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin inhibition of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced lesions of the urinary bladder correlated with inhibition of metabolism by bladder prostaglandin endoperoxide synthetase.
    Cohen SM; Zenser TV; Murasaki G; Fukushima S; Mattammal MB; Rapp NS; Davis BB
    Cancer Res; 1981 Sep; 41(9 Pt 1):3355-9. PubMed ID: 6790163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin hydroperoxidase-mediated 2-amino-4-(5-nitro-2-furyl) [14C]thiazole metabolism and nucleic acid binding.
    Mattammal MB; Zenser TV; Davis BB
    Cancer Res; 1981 Dec; 41(12 Pt 1):4961-6. PubMed ID: 6796263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative activation of benzidine and its derivatives by peroxidases.
    Josephy PD
    Environ Health Perspect; 1985 Dec; 64():171-8. PubMed ID: 3007087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of peroxidative activation of the bladder carcinogen 2-amino-4-(5-nitro-2-furyl)-thiazole (ANFT): comparison with benzidine.
    Lakshmi VM; Mattammal MB; Zenser TV; Davis BB
    Carcinogenesis; 1990 Nov; 11(11):1965-70. PubMed ID: 2121382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of peroxidase inhibitors on an in vivo metabolite of the urinary bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats.
    Rice JR; Spry LA; Zenser TV; Davis BB
    Cancer Res; 1988 Jan; 48(2):304-9. PubMed ID: 3121171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of aspirin on metabolism of acetaminophen and benzidine by renal inner medulla prostaglandin hydroperoxidase.
    Zenser TV; Mattammal MB; Rapp NS; Davis BB
    J Lab Clin Med; 1983 Jan; 101(1):58-65. PubMed ID: 6848614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of the renal carcinogen FNT by peroxidases.
    Walters FP; Wise RW; Lakshmi VM; Rice JR; Zenser TV; Davis BB
    Carcinogenesis; 1986 Sep; 7(9):1411-4. PubMed ID: 3091281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal metabolism of drugs and xenobiotics.
    Davis BB; Mattammal MB; Zenser TV
    Nephron; 1981; 27(4-5):187-96. PubMed ID: 6791039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism and disposition of bladder carcinogens in rat and guinea pig: possible mechanism of guinea pig resistance to bladder cancer.
    Dawley RM; Zenser TV; Mattammal MB; Lakshmi VM; Hsu FF; Davis BB
    Cancer Res; 1991 Jan; 51(2):514-20. PubMed ID: 1898713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of aromatic and heterocyclic amine bladder carcinogens: bioanalytical considerations.
    Mattammal MB; Lakshmi VM; Zenser TV; Davis BB
    J Pharm Biomed Anal; 1990; 8(2):151-8. PubMed ID: 2128813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transport of the renal carcinogen 3-hydroxymethyl-1-([3-(5-nitro-2-furyl)allydidene]amino) hydantoin by renal cortex and cooxidative metabolism by prostaglandin endoperoxide synthetase.
    Zenser TV; Balasubramanian TM; Mattammal MB; Davis BB
    Cancer Res; 1981 Jun; 41(6):2032-7. PubMed ID: 6786731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of aspirin on urinary bladder carcinogenesis initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats.
    Cohen SM; Hasegawa R; Sakata T; Johansson SL
    Cancer Res; 1989 Jan; 49(2):372-7. PubMed ID: 2491954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin H synthase-catalyzed activation of benzidine: a model to assess pharmacologic intervention of the initiation of chemical carcinogenesis.
    Zenser TV; Mattammal MB; Wise RW; Rice JR; Davis BB
    J Pharmacol Exp Ther; 1983 Dec; 227(3):545-50. PubMed ID: 6418878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic activation of carcinogenic aromatic amines by dog bladder and kidney prostaglandin H synthase.
    Wise RW; Zenser TV; Kadlubar FF; Davis BB
    Cancer Res; 1984 May; 44(5):1893-7. PubMed ID: 6424934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.